Your browser doesn't support javascript.
loading
No adverse events were observed in clozapine-treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan.
Hata, Masahiro; Fujimoto, Michiko; Kanai, Koji; Yoshiyama, Kenji; Nakatani, Yoshitaka; Nakabayashi, Daiji; Maemura, Saki; Kawata, Shinya; Hakozaki, Takaaki; Nishikura, Shuya; Umemoto, Aiko; Sasada, Toru; Iwata, Kazuhiko; Tanaka, Hideki; Mamoto, Akiko; Toi, Yuuki; Taniguchi, Norio; Saito, Makiko; Kimura, Yoshio; Kishimoto, Kazuko; Hayami, Megumi; Ikeda, Manabu.
Afiliación
  • Hata M; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Fujimoto M; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Kanai K; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Yoshiyama K; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakatani Y; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakabayashi D; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Maemura S; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Kawata S; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Hakozaki T; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Nishikura S; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Umemoto A; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Sasada T; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Iwata K; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Tanaka H; Osaka Psychiatric Medical Center, Osaka, Japan.
  • Mamoto A; Asakayama General Hospital, Osaka, Japan.
  • Toi Y; Asakayama General Hospital, Osaka, Japan.
  • Taniguchi N; Asakayama General Hospital, Osaka, Japan.
  • Saito M; Asakayama General Hospital, Osaka, Japan.
  • Kimura Y; Kosaka Hospital, Osaka, Japan.
  • Kishimoto K; Kosaka Hospital, Osaka, Japan.
  • Hayami M; Kosaka Hospital, Osaka, Japan.
  • Ikeda M; Kosaka Hospital, Osaka, Japan.
Neuropsychopharmacol Rep ; 41(2): 179-184, 2021 06.
Article en En | MEDLINE | ID: mdl-33606356
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Agranulocitosis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Neuropsychopharmacol Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Agranulocitosis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Neuropsychopharmacol Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos